SEVIKAR 40mg / 10mg tablets medication leaflet

C09DB02 olmesartan medoxomil + amlodipine • Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers

This combination of olmesartan medoxomil and amlodipine is used for the treatment of hypertension in patients not adequately controlled with a single medication. Olmesartan blocks angiotensin II receptors, while amlodipine is a calcium channel blocker that relaxes blood vessels.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.

Patients should be aware of potential side effects, such as dizziness, edema, or headaches. It is important to inform the doctor of any unusual symptoms.

Common side effects include dizziness, edema, headaches, and fatigue. In rare cases, severe reactions such as kidney failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about SEVIKAR 40mg / 10mg

Substance: olmesartan medoxomil + amlodipine

Date of last drug list: 01-06-2025

Commercial code: W68066002

Concentration: 40mg / 10mg

Pharmaceutical form: tablets

Quantity: 28

Product type: original

Price: 60.16 RON

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: DAIICHI SANKYO EUROPE GMBH - GERMANIA

Holder: LABORMED PHARMA S.A. - ROMANIA

Number: 5955/2013/02

Shelf life: 5 years

Concentrations available for olmesartan medoxomil + amlodipine

20mg/5mg, 40mg/10mg, 40mg/5mg

Compensation lists for SEVIKAR 40mg / 10mg LABORMED

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

60.16 RON

23.38 RON

36.78 RON